生物试剂
>
生化试剂
>
信号通路
> L-苯丙氨酸,4 [ 2-AMINO-6 -(3 - [ 2,2,2 -三氟-1 -氟[ 1,1'-联苯-4-乙氧基])] - 4-PYRIMIDINYL ]—
加入收藏 取消收藏

L-苯丙氨酸,4 [ 2-AMINO-6 -(3 - [ 2,2,2 -三氟-1 -氟[ 1,1'-联苯-4-乙氧基])] - 4-PYRIMIDINYL ]—  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

件 库存{{model.attbuying.number}}件
立即购买 加入购物车 下载说明书

看了又看
沸点：699.0±65.0 °C(Predicted)
密度：1.388±0.06 g/cm3(Predicted)
包装规格：1mg 5mg 25mg in glass bottle
产品简介：LP-533401是调节肠道内5-羟色胺产生的色氨酸羟化酶1抑制剂。
储备液保存：-80°C 2 years -20°C 1 year
靶点：Tryptophan hydroxylase
体外研究：LP-533401 completely inhibits serotonin production in Tph1–expressing cells (RBL2H3 cells) at a dose of 1 μM.
体内研究：Oral administration once daily for up to 6 weeks of this small molecule prevents the development of and fully rescues, in a dose-dependent manner, osteoporosis in ovariectomized rodents because of an isolated increase in bone formation. Pharmacokinetic studies in rodents show that LP-533401 level in the brain is negligible following oral administration, indicating that it is virtually unable to cross the blood-brain barrier. Mice treated repeatedly with LP-533401 (30–250 mg/kg per day) exhibit marked 5-HT content reductions in the gut, lungs, and blood, but not in the brain. After a single LP533401 dose (250 mg/kg), lung and gut 5-HT contents decrease by 50%, whereas blood 5-HT levels remain unchanged, suggesting gut and lung 5-HT synthesis. Adult, healthy mice treated with the Tph-1 inhibitor LP-533401 show 30% decrease in circulating serotonin levels, with a consequent 30% increase in osteoblast numbers. Administration of LP533401 to mice injected with EL4 cells inhibits the decrement in osteoblast numbers and trabecular bone volume, prolongs survial, and decreases leukemic infiltration.
保存条件：2-8°C
注意事项：1、为了您的安全和健康，请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。

猜你喜欢